Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15436071
[patent_doc_number] => 20200032219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => HERPES VIRUS STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/376089
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376089 | HERPES VIRUS STRAINS | Apr 4, 2019 | Abandoned |
Array
(
[id] => 16824257
[patent_doc_number] => 20210139550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => HINGES 1 AND/OR 4 MODIFIED DYSTROPHINS FOR DYSTROPHINOPATHY THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/045266
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045266 | HINGES 1 AND/OR 4 MODIFIED DYSTROPHINS FOR DYSTROPHINOPATHY THERAPY | Apr 2, 2019 | Pending |
Array
(
[id] => 16628775
[patent_doc_number] => 20210047428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHOD FOR GENERATING ANTIBODIES WITH IMPROVED SPECIFICITY AND/OR AFFINITY
[patent_app_type] => utility
[patent_app_number] => 17/043044
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043044 | METHOD FOR GENERATING ANTIBODIES WITH IMPROVED SPECIFICITY AND/OR AFFINITY | Mar 28, 2019 | Abandoned |
Array
(
[id] => 16760418
[patent_doc_number] => 20210105999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => COMPOSITIONS FOR PROLONGING THE SURVIVAL AFTER ORTHOTOPIC AND HETEROTOPIC XENOGENEIC HEART, KIDNEY, LUNG OR LIVER TRANSPLANTATIONS
[patent_app_type] => utility
[patent_app_number] => 17/042767
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042767 | COMPOSITIONS FOR PROLONGING THE SURVIVAL AFTER ORTHOTOPIC AND HETEROTOPIC XENOGENEIC HEART, KIDNEY, LUNG OR LIVER TRANSPLANTATIONS | Mar 28, 2019 | Pending |
Array
(
[id] => 16583143
[patent_doc_number] => 20210017545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => TALE-NUCLEASES FOR ALLELE-SPECIFIC CODON MODIFICATION AND MULTIPLEXING
[patent_app_type] => utility
[patent_app_number] => 17/041359
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041359
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041359 | TALE-NUCLEASES FOR ALLELE-SPECIFIC CODON MODIFICATION AND MULTIPLEXING | Mar 28, 2019 | Pending |
Array
(
[id] => 16583140
[patent_doc_number] => 20210017542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => AAV6 VARIANTS
[patent_app_type] => utility
[patent_app_number] => 17/042865
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042865 | AAV6 VARIANTS | Mar 28, 2019 | Pending |
Array
(
[id] => 16614007
[patent_doc_number] => 20210032660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => LIVER TROPIC RECOMBINANT AAV6 VECTORS THAT EVADE NEUTRALIZATION
[patent_app_type] => utility
[patent_app_number] => 17/042543
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042543 | LIVER TROPIC RECOMBINANT AAV6 VECTORS THAT EVADE NEUTRALIZATION | Mar 27, 2019 | Pending |
Array
(
[id] => 16583099
[patent_doc_number] => 20210017501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => MODIFIED ONCOLYTIC ADENOVIRUSES
[patent_app_type] => utility
[patent_app_number] => 17/040017
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040017 | MODIFIED ONCOLYTIC ADENOVIRUSES | Mar 18, 2019 | Pending |
Array
(
[id] => 14930527
[patent_doc_number] => 20190300901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => MATERIALS AND METHODS FOR MAKING A RECESSIVE GENE DOMINANT
[patent_app_type] => utility
[patent_app_number] => 16/290584
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290584 | MATERIALS AND METHODS FOR MAKING A RECESSIVE GENE DOMINANT | Feb 28, 2019 | Abandoned |
Array
(
[id] => 16168199
[patent_doc_number] => 10709739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Method for chemoselection
[patent_app_type] => utility
[patent_app_number] => 16/265546
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10433
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265546 | Method for chemoselection | Jan 31, 2019 | Issued |
Array
(
[id] => 17435936
[patent_doc_number] => 11261248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Restricted immunoglobulin heavy chain mice
[patent_app_type] => utility
[patent_app_number] => 16/265825
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 28429
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265825 | Restricted immunoglobulin heavy chain mice | Jan 31, 2019 | Issued |
Array
(
[id] => 15175427
[patent_doc_number] => 20190358305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => AAV-BASED GENE THERAPY FOR GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 16/264095
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264095
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264095 | AAV-BASED GENE THERAPY FOR GLAUCOMA | Jan 30, 2019 | Pending |
Array
(
[id] => 14225445
[patent_doc_number] => 20190124895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE
[patent_app_type] => utility
[patent_app_number] => 16/238589
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16238589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/238589 | Non-human animals having a humanized signal-regulatory protein gene | Jan 2, 2019 | Issued |
Array
(
[id] => 17135020
[patent_doc_number] => 11136566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Tale-protein scaffolds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/237901
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 58
[patent_no_of_words] => 33052
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16237901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/237901 | Tale-protein scaffolds and uses thereof | Jan 1, 2019 | Issued |
Array
(
[id] => 14464789
[patent_doc_number] => 20190184034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => USE OF hM4Di IN THE TREATMENT OF SEIZURE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/227326
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227326
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/227326 | USE OF hM4Di IN THE TREATMENT OF SEIZURE DISORDERS | Dec 19, 2018 | Abandoned |
Array
(
[id] => 15419673
[patent_doc_number] => 10542735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Humanized non-human animals with restricted immunoglobulin heavy chain loci
[patent_app_type] => utility
[patent_app_number] => 16/222951
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 49537
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222951 | Humanized non-human animals with restricted immunoglobulin heavy chain loci | Dec 16, 2018 | Issued |
Array
(
[id] => 15191275
[patent_doc_number] => 10493108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Non-invasive in vivo imaging and methods for treating diabetes
[patent_app_type] => utility
[patent_app_number] => 16/181853
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11303
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/181853 | Non-invasive in vivo imaging and methods for treating diabetes | Nov 5, 2018 | Issued |
Array
(
[id] => 18589174
[patent_doc_number] => 11738046
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Macrophage cell therapy to treat orthopedic injury
[patent_app_type] => utility
[patent_app_number] => 16/179298
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 7
[patent_no_of_words] => 11800
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179298
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179298 | Macrophage cell therapy to treat orthopedic injury | Nov 1, 2018 | Issued |
Array
(
[id] => 15510299
[patent_doc_number] => 10561716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Prostate cancer vaccine
[patent_app_type] => utility
[patent_app_number] => 16/165602
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 11
[patent_no_of_words] => 11476
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165602
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165602 | Prostate cancer vaccine | Oct 18, 2018 | Issued |
Array
(
[id] => 16784428
[patent_doc_number] => 10986820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Common light chain mouse
[patent_app_type] => utility
[patent_app_number] => 16/165987
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19799
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165987 | Common light chain mouse | Oct 18, 2018 | Issued |